SCHEMBL23094187

SCHEMBL23094187

COc1ccccc1C/C=N/OC(=O)COc1cc(C)cc(C)c1C

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 5/20 0.68
▸ MAPK1 P28482 4/20 0.68
▸ TDP1 Q9NUW8 2/20 0.52
▸ MAPT P10636 2/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HTT P42858 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ ANO1 Q5XXA6 1/20 0.39
▸ ANO2 Q9NQ90 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21467722 0.86 L3MBTL1 (0.53) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL23094184 0.81 L3MBTL1 (1.00) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL21467721 0.71 L3MBTL1 (0.74) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL21467747 0.70 ALDH1A1 (0.47) L3MBTL1TDP1MAPTHTTALDH1A1
SCHEMBL23094202 0.69 TDP1 (0.81) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL21467764 0.68 TDP1 (1.00) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL9016489 0.67 L3MBTL1 (0.56) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL9016474 0.67 L3MBTL1 (0.56) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL23094164 0.66 TDP1 (1.00) L3MBTL1MAPK1TDP1MAPTSMN1; SMN2
SCHEMBL23094267 0.66 L3MBTL1 (0.47) L3MBTL1MAPK1TDP1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 L3MBTL1 2077/4885MAPK1 3035/4885TDP1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback